Verition Fund Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.92M | Buy |
87,826
+12,366
| +16% | +$824K | 0.03% | 583 |
|
|
2026
Q1 | $4.74M | Buy |
75,460
+18,188
| +32% | +$1.27M | 0.03% | 607 |
|
|
2025
Q4 | $3.8M | Sell |
57,272
-76,815
| -57% | -$4.97M | 0.01% | 1084 |
|
|
2025
Q3 | $9.02M | Buy |
134,087
+52,115
| +64% | +$4.12M | 0.04% | 598 |
|
|
2025
Q2 | $7.16M | Sell |
81,972
-9,594
| -10% | -$752K | 0.03% | 761 |
|
|
2025
Q1 | $6.25M | Buy |
91,566
+14,891
| +19% | +$1.22M | 0.03% | 692 |
|
|
2024
Q4 | $5.96M | Buy |
76,675
+46,237
| +152% | +$3.42M | 0.02% | 782 |
|
|
2024
Q3 | $2.04M | Sell |
30,438
-11,159
| -27% | -$916K | 0.01% | 1404 |
|
|
2024
Q2 | $4.72M | Buy |
41,597
+13,001
| +45% | +$1.64M | 0.03% | 766 |
|
|
2024
Q1 | $3.97M | Buy |
28,596
+12,150
| +74% | +$1.53M | 0.03% | 814 |
|
|
2023
Q4 | $2.04M | Sell |
16,446
-41,991
| -72% | -$4.29M | 0.02% | 832 |
|
|
2023
Q3 | $5.45M | Buy |
+58,437
| New | +$6.59M | 0.06% | 399 |
|
|
2023
Q2 | – | Sell |
-41,209
| Closed | -$4.98M | – | 2281 |
|
|
2023
Q1 | $4.79M | Sell |
41,209
-6,742
| -14% | -$755K | 0.07% | 381 |
|
|
2022
Q4 | $5.43M | Sell |
47,951
-2,300
| -5% | -$253K | 0.08% | 289 |
|
|
2022
Q3 | $4.05M | Buy |
50,251
+37,574
| +296% | +$3.18M | 0.05% | 524 |
|
|
2022
Q2 | $945K | Sell |
12,677
-52,563
| -81% | -$4.8M | 0.02% | 1059 |
|
|
2022
Q1 | $8.34M | Buy |
65,240
+18,244
| +39% | +$2M | 0.1% | 195 |
|
|
2021
Q4 | $6.31M | Buy |
46,996
+41,968
| +835% | +$6.03M | 0.05% | 282 |
|
|
2021
Q3 | $687K | Buy |
+5,028
| New | +$634K | 0.01% | 1089 |
|
|
2021
Q2 | – | Sell |
-21,484
| Closed | -$1.93M | – | 1941 |
|
|
2021
Q1 | $1.93M | Buy |
21,484
+1,068
| +5% | +$100K | 0.02% | 431 |
|
|
2020
Q4 | $1.89M | Buy |
+20,416
| New | +$1.82M | 0.02% | 387 |
|
|
2020
Q3 | – | Sell |
-7,916
| Closed | -$802K | – | 1128 |
|
|
2020
Q2 | $802K | Buy |
+7,916
| New | +$708K | 0.03% | 475 |
|
|
2020
Q1 | – | Sell |
-23,716
| Closed | -$1.3M | – | 718 |
|
|
2019
Q4 | $1.3M | Buy |
+23,716
| New | +$1.12M | 0.02% | 374 |
|
|
2019
Q3 | – | Sell |
-5,808
| Closed | -$218K | – | 1113 |
|
|
2019
Q2 | $218K | Sell |
5,808
-14,164
| -71% | -$445K | 0.01% | 952 |
|
|
2019
Q1 | $595K | Buy |
+19,972
| New | +$702K | 0.02% | 589 |
|
|
2018
Q4 | – | Sell |
-117,588
| Closed | -$4.21M | – | 913 |
|
|
2018
Q3 | $4.21M | Buy |
117,588
+91,592
| +352% | +$2.84M | 0.15% | 125 |
|
|
2018
Q2 | $617K | Buy |
+25,996
| New | +$551K | 0.04% | 606 |
|
|
2017
Q3 | – | Sell |
-28,880
| Closed | -$528K | – | 1206 |
|
|
2017
Q2 | $528K | Buy |
+28,880
| New | +$533K | 0.05% | 391 |
|
|
2017
Q1 | – | Sell |
-19,600
| Closed | -$293K | – | 1230 |
|
|
2016
Q4 | $293K | Sell |
19,600
-7,452
| -28% | -$132K | 0.03% | 839 |
|
|
2016
Q3 | $593K | Buy |
+27,052
| New | +$602K | 0.06% | 409 |
|
|
2015
Q4 | – | Sell |
-19,188
| Closed | -$412K | – | 482 |
|
|
2015
Q3 | $412K | Buy |
+19,188
| New | +$428K | 0.11% | 253 |
|
|
2014
Q4 | – | Sell |
-20,800
| Closed | -$208K | – | 431 |
|
|
2014
Q3 | $208K | Buy |
+20,800
| New | +$213K | 0.03% | 548 |
|
Other funds holding DXCM
Verition Fund Management's DXCM Position: Q2 2026 in Review
Verition Fund Management increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $824K and bringing the position to 87,826 shares worth $5.92M. The position accounts for 0.03% of the portfolio, ranked #583.
Verition Fund Management first reported a position in DXCM in Q3 2014 and has held it in 32 quarters since. The position peaked at $9.02M in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Verition Fund Management held 87,826 shares of DexCom worth $5.92M as of Q2 2026.
- Verition Fund Management bought 12,366 DexCom shares in Q2 2026, an estimated $824K.
- DexCom made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #583 holding.
- Verition Fund Management first reported a position in DexCom in Q3 2014 and has held it in 32 quarters since.
- Verition Fund Management's DexCom position peaked at $9.02M in Q3 2025.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.